SMITH SCOTT THOMAS bought ASND
June 2, 2026 · Form 4 insider transaction
SMITH SCOTT THOMAS bought 100 shares of Ascendis Pharma A/S at $219.00 per share, a transaction worth $21.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
100
Price
$219.00
Total value
$21.9K
InsiderSMITH SCOTT THOMAS
RoleOfficer
CompanyAscendis Pharma A/S (ASND)
SecurityOrdinary Shares
Transaction codeP: Open-market purchase
Transaction dateJune 2, 2026
Filing dateJune 2, 2026
Shares owned after4,367
OwnershipDirect
10b5-1 planNo
AmendedNo